Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »

Patrick Driscoll › Comments

Patrick Driscoll
Companies & Markets: Global *Spinal* Surgery Devices Market Forecast to Reach *...* - http://www.google.com/url...
If you actually bother to count all of the spine surgery devices on the market, you will see that the market is ALREADY at $13 billion. (This is like talking about the real estate market, but excluding everything west of the Mississippi.) The "analysis" described here is being marketed by "Companies and Market" but was researched and produced by "GBI Research" which publishes research on "pharmaceuticals, medical devices, alternative energy, power, clean technology, oil and gas and chemicals". Such diluted research effort is important if you want to really do a good job detailing the spine surgery market, which of course is so closely related to energy, power, clean tech, etc., etc. You have to also cover interprocess spinous spacers, lumber and cervical artificial discs, vertebroplasty, kyphoplasty... To see what should be covered in a Global Market on Spine surgery, see http://www.mediligence.com/rpt.... - Patrick Driscoll
Patrick Driscoll
Repeal med device tax - Boston Herald - http://news.google.com/news...
Boston Herald once again confirms its lack of journalistic credibility. - Patrick Driscoll
Patrick Driscoll
Study finds Boston's elderly homeless sicker than others - http://www.physorg.com/news...
It's sad to think that a study needs to be done to confirm something that is patently obvious. This is indeed a valuable study, but not because it's something we didn't already know. - Patrick Driscoll
Patrick Driscoll
Microsoft plans to open 75 retail stores in the next 3 years - http://feedproxy.google.com/~r...
They will do well if there isn't an Apple store in the vicinity. Locally, there is a mall with both and I find it stunning how much Microsoft can try to copy Apple with reps in the store dressed in Windows version of Apple, yet you come out of the store thinking, I've seen all this stuff before and NONE of it is unique or cool. - Patrick Driscoll
Patrick Driscoll
Blog - Google+ Marks The End of Blogging As a Means of Personal Expression - http://feeds.technologyreview.com/click...
This may well be true for the social media people who blog about blogging or whose social media is directed to social media, but the audience whose primary focus is NOT social media (maybe medical technologies, say?) are still warming to the idea that independent writers and analysts with insights in their field are routinely offering valuable content that is relevant and accessible to them. Not all new technology demands simultaneous obsolescence of old technology. - Patrick Driscoll
Patrick Driscoll
French regulators ban the words Facebook and Twitter from TV and radio - http://venturebeat.com/2011...
Backwards, plain and simple. - Patrick Driscoll
Patrick Driscoll
Orexigen Says FDA’s Requests for Contrave Trial Aren’t ‘Necessary or Feasible’ - http://blogs.wsj.com/health...
Although I have a little background in statistics, I can't claim to know what would be an appropriate sample to establish confidence in the clinical results (up or down) for Contrave, but my instincts tell me that a trial of 60,000 to 100,000 patients smacks of something other than statistics. If properly designed, with sufficient representation of patient cohorts, I have to believe that a number much closer to Orexigen's 12,000-15,000 would be necessary. It seems that there is a myopia in force that is disregarding the risk associated with rejecting an overwhelming number of obesity drugs/combinations. - Patrick Driscoll
Patrick Driscoll
Two Out of Three US Medtech Manufacturers Prefer Europe - http://medtechinsider.com/archive...
The important consideration here is not that U.S. companies get CE Mark first, but what share of them do this now versus how many did this five or ten years ago. Europe has long offered the opportunity to get an earlier and easier market introduction. In the current dialogue about how woefully slow or inadequate the FDA is, it's easy to point out that most companies pursue Europe first, but it would be more telling to reveal if the share of companies pursuing Europe first has increased and, if so, by how much. It is also worth underscoring that, in any case, most companies use the easier market introduction in Europe to gain much-need revenue streams with an eye to their ultimate target, the U.S. market. Europe often is therefore more often just a stepping stone. - Patrick Driscoll
Patrick Driscoll
NASA to abandon trapped rover Spirit - http://www.physorg.com/news...
People like to anthropomorphise like this was R2D2, but this rover's amazing accomplishments are due to the foresight and imagination of the engineers who designed and controlled it during its mission. These ladies and gentlemen are rock stars. - Patrick Driscoll
Patrick Driscoll
Cultured men are happier and healthier - http://medicalxpress.com/news...
Does the dog wag the tail or is it the other way around? Do they have better, more satisfied lives because of culture or do they already have a better life, as evidenced by their ability to afford the time and cost of such culture? Will the blue collar worker be happier and healthier if he simply goes to galleries, museums and the theatre? The study, or at least the abstract, presumes causality between culture and well being, rather than culture simply reflecting a well being already attained. - Patrick Driscoll
Patrick Driscoll
The Urgency of Medicaid Reform - http://thehealthcareblog.com/blog...
I must praise the total lack of bias evident in this writer from FORBES. I am impressed with his ability to blithely ignore points of view that hold no less merit than his, the fluid way in which he is able to insert the phrase "welfare dependence" and the grace with which he acknowledges that there is "a level of poverty at which Medicaid is better than nothing at all...but most people can afford to take on more responsibility for their own care, and indeed would be far better off doing so" and can do so without any supporting facts but, indeed, with a straight face [insert golf clap here]. Well done, sir. - Patrick Driscoll
Patrick Driscoll
Location a major factor in NZ quake devastation - http://www.physorg.com/news...
Because, of course, that's where it happened. - Patrick Driscoll
Patrick Driscoll
Reportlinker Adds Global <b>Insulin</b> Pumps (External) Industry <b>...</b> - http://www.google.com/url...
The global diabetes market, including continuous and standard blood glucose monitoring, insulin, non-insolin drugs, pens/syringes and other delivery, insulin pumps and emerging technologies ("artificial" pancreas, cell therapies, gene therapies, vaccines and others) are covered in the MedMarket Diligence report #D510. See http://www.mediligence.com/rpt... for detailed description, table of contents, and list of exhibits. - Patrick Driscoll
Patrick Driscoll
$30 Million Cryoablation Market Expected To Take Off At The Expense Of Radiofrequency Over The Next Five Years - http://www.medicalnewstoday.com/article...
Late to the party... We addressed this months ago in a global report, http://www.mediligence.com/rpt.... - Patrick Driscoll
Patrick Driscoll
Medical Devices Driving Up Heart Care Costs - http://www.bio-medicine.org/medicin...
I abhor simplistic analyses. The increased cost of treating coronary artery disease has gone up 1.5% per year (after adjustment for inflation) and the similar increase for treatment of chronic heart failure is 2.3% per year. While I can speak to the device cost in congestive heart failure, I can say that the average unit price of drug-eluting stents is *declining* about 6.3% per year, so, if overall costs are being addressed on a per patient basis, then the increased cost is in physician fees, hospital fees, healthcare insurance -- many other sources. If, however, these increased costs are in the aggregate (i.e., not per patient), then the increase in cost is due to a growing caseload of patients being treated with these technologies (and taking on physician/hospital/insurance costs), the alternative for which is either (a) lower quality of life or (b) death. It's always so much easier to focus on medical device costs rather than death. OK, I yield the soap box to someone else. - Patrick Driscoll
Patrick Driscoll
Has the U.S. Health Technology Sector Run Out of Gas? - The Conversation - Harvard Business Review - http://blogs.hbr.org/cs...
While the premiums commanded by drugs and devices have been pinched by the advance of managed care and a relentless focus on cost, medical technology has responded with a startling degree of innovation - in the demands of medical technology to compete on cost against a broader array of competitive alternatives. In this midst of this process, the human genome was mapped, driving entirely new disciplines of drug development. The dvelopment of devices has advanced to the point where they defy definitions as device/drug/drug-delivery/resorbable. Medical technology is regenerating cells, tissues, organs. Stem cell and other pluripotent cell technologies are in active use with a litany of treatments also poised to reach patient populations that as yet have been largely or wholly untouched by medicine. The author's postulate, however predicated on the past advances of medtech being remarkable (while quite true) simply fails in its straw man presumption that the advances have ceased. Medical... - Patrick Driscoll
Patrick Driscoll
These technologies have advanced the clinical and commercial reality of biotech more than any other in the promise-heavy field. - Patrick Driscoll
Patrick Driscoll
Cell therapy for diabetes eventually, but artificial pancreas sooner - http://mediligence.com/blog...
Technologies Like Medtronic's Paradigm are a great example of how medtech achieves a solution now and almost preempts the promise of alternative biotechnology solutions. - Patrick Driscoll
Patrick Driscoll
Brief: technologies under development at medtech startups - http://mediligence.com/blog...
These are in development at Apama Medical, TVA Medical, Leto Medical, Cerevast Therapeutics, CuMed, Houston Medical Robotics, Cradle Medical, IonMed Ltd, ReQuisite Biomedical, Amedrix GmbH, Novita Therapeutics, Minerva Surgical, CytoSolv, OsteoSpring Medical, Endomimetics, Imtec Biomedical, Bioactive Surgical, EMKinetics, NonLinear Technologies Ltd, Oval Medical Technologies Ltd and Z&Z Medical Holdings. - Patrick Driscoll
Patrick Driscoll
Medical technology funding only modest so far in March - http://mediligence.com/blog...
Includes TransMedics, Inc.'s $36 million, Cheetah Medical, Inc.'s $20 million, Carticept Medical, Inc.'s $20 million and Spinal Restoration, Inc.'s $20 million. - Patrick Driscoll
Patrick Driscoll
Wound closure products sales are expected to grow 3.5% (CAGR),reaching over $4 billion by 2013. Get the facts! - http://www.medicaldevicestoday.com/2009...
It's worth noting that a CAGR of 3.5% is almost flatline and, further, there are much higher growth segments within the wound market. See http://mediligence.com/rpt.... - Patrick Driscoll
Patrick Driscoll
New Sticky Sealant Closes Wounds and Stops Bleeding - http://medtechinsider.com/...
This included research provided by MedMarket Diligence. See http://mediligence.com/rpt... - Patrick Driscoll
Health Issues
MarketsandMarkets: Global Top Ten Medical Device Technologies ... - http://marketsandmarkets.wordpress.com/2009...
http://www.marketsandmarkets.com/Market-.... Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes ...
Not really sure what the phrase "accelerated the accuracy of clinical outcomes" means. Minimally invasive surgery is not a technology, it's a goal. Many different technologies may be involved (like laparoscopy, percutaneous procedures, etc.) and some of them are not really breakthroughs but they do achieve this goal. - Patrick Driscoll
Tech Industry News
MarketsandMarkets: Global Top Ten Medical Device Technologies ... - http://marketsandmarkets.wordpress.com/2009...
http://www.marketsandmarkets.com/Market-.... Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes ...
A better look at the top device technologies is at http://www.mediligence.com/web-fil.... We've been tracking the top technologies, and platforms, for years. - Patrick Driscoll
pericles
Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why. - http://www.wired.com/medtech...
Read about the latest medical technology, pharmaceuticals and biotech trends including diets, drugs, genetics, stem cells, medicine, health, and cloning from Wired.com. - pericles
It's fascinating to me that this can be possible. In an analogous turn, recently a surgical procedure for a type of spine surgery called vertebroplasty was found to be virtually equivalent to the control procedure, for all intent and purposes a "placebo". - Patrick Driscoll
Patrick Driscoll
advanced medical technologies - Minimally invasive spine surgery becoming technology-enabled - http://mediligence.com/blog...
Despite questions that have arisen about some minimally invasive approaches (e.g., vertebroplasty), MIS procedures are steadily gaining share of spine surgery procedures. - Patrick Driscoll
Patrick Driscoll
Future Physicians Weigh in on Importance of Technology in Medicine | mobihealthnews - http://mobihealthnews.com/4066...
I am always fascinated by the notion that the word "technology" is almost universally discussed in the context of computers, cell phones, etc., EVEN if discussing technology in medicine. I read "medicine" and "technology" and I think "medical technology", not the latest iPhone. - Patrick Driscoll
Patrick Driscoll
Patrick Driscoll
These technologies come from a database of *hundreds* of recent medtech startups (and by "recent", I don't mean the old, tired "Medtech Insight" approach. - Patrick Driscoll
Patrick Driscoll
Founder of MedMarket Diligence, industry analyst, author, blogger. - Patrick Driscoll
Other ways to read this feed:Feed readerFacebook